Canine Atopic Dermatitis: Diagnosis, Treatment, and Outlook
Canine atopic dermatitis is a complex, itchy inflammatory disease. Management often combines several measures and follow-up: relieving a flare and maintaining long-term control involve different decisions. Dogs do not all need the same medicines or respond in the same way.
1. Symptoms and course
It may cause itching, licking or chewing of the paws, face rubbing, redness, and lesions in the armpits, groin, or other areas. Persistent scratching can lead to hair loss, thickening, and darkening of the skin. Ear disease and yeast or bacterial overgrowth may occur alongside it. Some dogs have seasonal signs; others are affected year-round. [1,2]
Record the age when signs began, months when they worsen, sleep disruption, and responses to earlier treatment. Photos taken in similar lighting and a personal itch score from 0 to 10 can help discuss trends, but do not replace an examination.
2. Differential diagnoses
Before attributing itching to atopy, investigate fleas and other ectoparasites, skin infections, food reactions, and other skin diseases. Endocrine disorders and keratinization problems can make infections more likely; less common conditions may require additional testing. The distribution of lesions helps guide the assessment, but no location alone establishes the diagnosis. [1,2]
Food allergy and environmental atopy can coexist. Improvement with a corticosteroid does not confirm atopy: other itchy diseases may temporarily respond to the same medicine.
3. A stepwise diagnosis
- History and skin examination: review the skin, paws, ears, exposures, diet, and previous treatment.
- Targeted tests: cytology and parasite assessment; skin scrapings, cultures, or other tests when findings support them.
- Treat identified problems and reassess: determine how much itching remains once infections and parasites are controlled.
- Diet trial when appropriate: especially for nonseasonal itching or associated digestive signs, using supervised elimination and challenge.
- Integrated clinical diagnosis: consider the history and presentation and rule out similar diseases. [1]
Intradermal or environmental IgE tests are mainly used to select allergens if immunotherapy is considered after a clinical diagnosis. A positive result alone does not confirm that an allergen explains all lesions. A 2025 systematic review identifies limitations in standardization and performance; results need clinical interpretation. [3]
4. Treating an active flare
The 2026 ICADA guidelines distinguish a reactive phase, to relieve current signs, from a proactive phase, to maintain remission. Severity, infections, concurrent disease, safety, cost, and response guide the plan. [4]
During a flare, the goals are to interrupt the itch–skin damage cycle, control infection if present, and review triggers. Red skin does not automatically call for an antibiotic. Confirmed findings are treated along with the pain or discomfort they cause.
| Option a veterinarian may consider | Use and points to review |
|---|---|
| Glucocorticoids | Rapid control of inflammation and itching; monitor thirst, appetite, urination, and effects with continued use. |
| Oclacitinib, a JAK inhibitor | May provide rapid relief; age, infections, and history affect selection. |
| Lokivetmab, an antibody to IL-31 | Injectable antipruritic option; response and lesion control vary. |
| Cyclosporine | More suitable for sustained control than immediate rescue; takes weeks and requires review of tolerance and interactions. |
| Topical therapy | Baths, barrier products, or localized anti-inflammatory treatment, according to lesions and tolerance. |
These medicines are not interchangeable and should not be combined casually. The professional determines dose, restrictions, and local availability. Report vomiting, diarrhea, or other changes during treatment. [4–6]
5. Maintenance treatment
Once the flare improves, agree on the least intensive effective plan to reduce relapses; do not abruptly stop medicines that may require tapering. It may include skin-barrier care, intermittent treatment, parasite prevention, and control of recurrent infections. Rescue medicines should come with clear instructions on when to use them and when to call. [4]
Allergen-specific immunotherapy aims to modify the response to selected allergens and may reduce the need for other treatments in some dogs. It is assessed over months, not as immediate relief, and success is not guaranteed. It requires compatible testing and history, as well as a plan for administration and monitoring. [5]
At home, use agreed products and record exposures and response. Avoid irritants that worsen your dog’s signs; there is no need to try to eliminate every household allergen or buy supplements without a specific clinical question. Baths need a product and frequency chosen for the patient, not a single schedule for every skin condition.
6. Follow-up and plan review
Arrange a check after starting or changing treatment and further visits according to stability and the medicine. Compare itch, sleep, lesions, ears, tolerance, and how easy the plan is to follow. Some therapies call for a blood count, biochemistry, or other tests; the veterinarian decides which tests and when. [5,6]
If effectiveness decreases, review infection, parasites, administration, and exposure changes before increasing medication. Persistent ear disease needs its own assessment. Inability to sleep, pain, or extensive wounds justify prompt consultation; breathing difficulty, rapid facial swelling, or collapse require emergency care.
7. Outlook
This is usually a chronic disease with better periods and flares. Many dogs maintain a good quality of life with a practical plan and follow-up, but adjustments may be needed. The goal is to reduce suffering and relapses while keeping adverse effects acceptable, without promising a definitive cure.
Request a veterinary consultation and read the ear disease guide.
References and limits of the evidence
- Hensel et al., 2015. ICADA: diagnosis and identification of allergens. Open text. DOI: 10.1186/s12917-015-0515-5.
- Merck Veterinary Manual: Atopic skin conditions in dogs and cats. Clinical framework.
- Systematic review of sensitization tests, 2025. Indexed abstract.
- Mueller et al., 2026. ICADA therapeutic update. DOI: 10.1111/vde.70128. The indexed abstract was checked; medication details were cross-checked with AAHA.
- AAHA 2023: treatments for flares and long-term management.
- AAHA 2023: full allergic disease guideline.
Sources checked October 29, 2026. This educational guide supports an individual plan: medicines, doses, procedures, and follow-up should be directed by the responsible veterinarian.
Treatment options and related reading
To organize the alternatives, read the dermatitis treatment guide, Apoquel, and Cytopoint. These information pages can help prepare questions; the appropriate treatment depends on the patient.